methylprednisolone hemisuccinate has been researched along with 2019 Novel Coronavirus Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 4 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bansal, SK; Blume, GM; Kattah, JC; Kaufman, JR; Nelson, JL; Woods, FR; Zhang, X | 1 |
Awwad, C; Chin, J; Chin, K; Griffin, DO; Jensen, A; Khan, M; Parnell, R; Patel, D; Saad, J | 1 |
Forde, CT; Koumpa, FS; Manjaly, JG | 1 |
Birkenbach, MP; Dapaah-Afriyie, K; Moustafa, A; Selvaraj, V | 1 |
4 other study(ies) available for methylprednisolone hemisuccinate and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Postinfectious SARS-CoV-2 Opsoclonus-Myoclonus-Ataxia Syndrome.
Topics: Cerebellar Ataxia; Clonazepam; COVID-19; Female; Humans; Immunoglobulin G; Methylprednisolone Hemisuccinate; Ocular Motility Disorders; Opsoclonus-Myoclonus Syndrome; Receptors, GABA-A; Rituximab; RNA, Viral; SARS-CoV-2 | 2022 |
Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease.
Topics: Acute Disease; Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Betacoronavirus; Biomarkers; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Cytokine Release Syndrome; Enoxaparin; Female; Fibrin Fibrinogen Degradation Products; Humans; Hypoxia; Male; Methylprednisolone Hemisuccinate; Middle Aged; Pandemics; Pneumonia, Viral; Pulmonary Embolism; Rivaroxaban; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Sudden irreversible hearing loss post COVID-19.
Topics: Administration, Oral; Betacoronavirus; Coronavirus Infections; COVID-19; Glucocorticoids; Hearing Loss, Sudden; Humans; Injections; Male; Methylprednisolone Hemisuccinate; Middle Aged; Pandemics; Pneumonia, Viral; Prednisolone; SARS-CoV-2 | 2020 |
COVID-19-induced granulomatosis with polyangiitis.
Topics: Anti-Inflammatory Agents; Biopsy; COVID-19; Diagnosis, Differential; Female; Granulomatosis with Polyangiitis; Humans; Immunologic Factors; Kidney; Methylprednisolone Hemisuccinate; Middle Aged; Rituximab; SARS-CoV-2 | 2021 |